WebMar 27, 2024 · occurred in ENHERTU -treated patients, ENHERTU is to be used in close collaboration with a respiratory disease expert. Closely observe patients during therapy by monitoring for early signs or symptoms of ILD (such as dyspnea, cough or fever) and regularly perform peripheral artery oxygen saturation (SpO. 2) tests, chest X-ray scans … WebENHERTU is a HER2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with: – In the neoadjuvant or adjuvant setting and have …
FDA approves fam-trastuzumab deruxtecan-nxki for HER2-low …
WebDec 7, 2024 · The internet can be a valuable resource for a patient who wants to find out more information about their disease. However, remember that not every website contains accurate and reliable information. The websites listed below offer cancer education information in Spanish. American Cancer Society WebApr 6, 2024 · ENHERTU ® (trastuzumab deruxtecan; fam-trastuzumab deruxtecan-nxki in the U.S. only) is a HER2 directed antibody drug conjugate (ADC). Designed using Daiichi Sankyo’s proprietary DXd ADC... java 语言规范
Support and Resources ENHERTU® (fam-trastuzumab …
Webpneumonitis, can occur in patients treated with ENHERTU. In clinical studies, of the 234 patients with unresectable or metastatic HER2-positive breast cancer treated with ENHERTU 5.4 mg/kg, ILD occurred in 9% of patients. Fatal outcomes due to ILD and/or pneumonitis occurred in 2.6% of patients treated with ENHERTU. WebFeb 1, 2024 · Description and Brand Names. Drug information provided by: IBM Micromedex US Brand Name. Enhertu; Descriptions. Fam-trastuzumab deruxtecan-nxki injection is used to treat HER2-positive metastatic (cancer that has spread to other parts of the body) or unresectable (cancer that cannot be removed with surgery) breast cancer in … WebFeb 1, 2024 · The safety of Enhertu was evaluated in a pooled analysis of 234 patients with unresectable or metastatic HER2-positive breast cancer who received at least one dose of Enhertu 5.4 mg/kg in DESTINY … java 语言检测